MYGN

News Myriad Genetics (MYGN) Advances in MRD Space With New Patent - Zacks Investment Research

14d ago

News Myriad Genetics (MYGN) Banks on Innovation Amid Macro Woes

14d ago

News Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing

14d ago

News QIAGEN (QGEN) Develops Test for Research and CDx Application

14d ago

Insider trade Purchase by Paul Bisaro

18d ago

News Myriad Genetics in record sell-off after Q1 miss

27d ago

News Myriad reiterates $860M-$880M 2026 revenue outlook while advancing Precise MRD and FirstGene launches

27d ago

SEC filing MYGN Reports $200.4M Q1 Rev, $34.1M Net Loss, $0.36 EPS, +2% YoY Rev, 68.7% Gross Margin, FDA Approves MyChoice CDx Companion, Launches Precise MRD, Cancer Care Continuum +13% Vol, $120.2M Rev, $124.4M Cash

28d ago

Insider trade Purchase by Samraat S. Raha (President and CEO)

84d ago

Insider trade Purchase by Louise S. Phanstiel

94d ago

News Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights

137d ago

News Myriad Genetics Q4 and 2025 revenue ranges include consensus

141d ago

Scanner Unusual volume (z=5.4)

160d ago

Scanner Unusual volume (z=5.4)

162d ago

Scanner Unusual volume (z=5.4)

163d ago

Scanner Unusual volume (z=5.4)

164d ago